Avantor, Inc.

Avantor, Inc. is a Humankind 100 company whose ranking is based on its Humankind Value, a proprietary metric that provides an estimate of the overall dollar amount a company creates for investors, consumers, employees, and society at large.

Avantor, Inc. supplies chemicals and materials that aid in healthcare. Its services include procurement, clinical services, lab equipment, and digital services. Avantor helps researchers and drug producers by supplying materials and guidance throughout the process.

Ticker: AVTR

Humankind Value: $72.9 B

Revenue: $5.6 B

Market Cap: $19.5 B

(All values are in US Dollars, where M=Million, B=Billion, T=Trillion.)

Medical device research and development is responsible for substantive gains in length and quality of life. Avantor, Inc. generates positive Humankind Value on balance. Notable sources of positive value are Medical Devices ($50.9 B), Healthcare R&D ($9.3 B), and Medical Services ($5.0 B). The value associated with Medical Devices, Healthcare R&D, and Medical Services is linked to an estimate of 1,351,826.9 additional years lived by people worldwide. The Humankind Value of this company can improve with reductions in Breastmilk Substitutes (-$752.4 M) and Opioid Abuse (-$739.3 M). Medical Devices, Healthcare R&D, Medical Services, Breastmilk Substitutes, and Opioid Abuse are mostly or entirely a result of supply-chain relationships. While this company has a positive Humankind Value when studied in isolation, consideration of supply chain interactions pushes its Humankind Value higher.

How the Humankind Value Methodology Drives the Rankings

We take a quantitative, data-driven approach to estimating the economic impact that companies have on investors, customers, employees, and society at large, rolling social responsibility into a single dollar value that we use to represent what a company is contributing to humanity. As far as we can tell, we're the first ones doing it this way.

LEARN MORE ABOUT OUR RESEARCH
How Methodology Drives the Rankings